SCHEMBL7986529

SCHEMBL7986529

O=C(Nc1oc(-c2cccc(-c3ccc(F)cc3)c2O)nc1-c1ccsc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.44
ADCY1 Q08828 5/20 0.43
FLT1 P17948 2/20 0.42
KIT P10721 1/20 0.42
ADCY8 P40145 2/20 0.39
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
HSP90AA1 P07900 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
CCR6 P51684 1/20 0.39
MAPK14 Q16539 1/20 0.39
FLT4 P35916 1/20 0.38
MEN1 O00255 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7986016 0.91 KDR (0.46) KDRFLT1KITHTTSMN1; SMN2
SCHEMBL7969458 0.91 KDR (0.46) KDRFLT1KITSMN1; SMN2TDP1
SCHEMBL7980109 0.88 KDR (0.44) KDRFLT1KITHTTSMN1; SMN2
SCHEMBL7982851 0.88 KDR (0.52) KDRFLT1HPGDMAPK14FLT4
SCHEMBL7969516 0.86 KDR (0.44) KDRFLT1KITSMN1; SMN2CYP1A2
SCHEMBL7746570 0.81 KDR (0.49) KDRFLT1KITSMN1; SMN2POLB
SCHEMBL7969519 0.80 KDR (0.44) KDRFLT1KITSMN1; SMN2CYP1A2
SCHEMBL7982719 0.79 KDR (0.53) KDRFLT1POLBFLT4KMT2A
SCHEMBL7979692 0.77 KDR (0.54) KDRFLT1FLT4RAB9ANPC1
SCHEMBL7981592 0.77 ADCY1 (0.45) ADCY1HTTSMN1; SMN2TDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed